AzTrials
AzTrials

Femur Neck FractureNCT05181566

Metal Ion Levels in Total Hip Arthroplasty (THA) With Modular Dual Mobility Cup Compared to Conventional THA

A study testing Total hip replacement arthroplasty using modular dual mobility cup and Total hip replacement arthroplasty using conventional acetabular cup in people with Femur Neck Fracture and Arthroplasty Complications, run by Korea University Guro Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

After total hip arthroplasty using an 'Modular Dual Mobility' acetabular cup, which is effective in reducing the risk of dislocation, one of the serious complications occurring after total hip arthroplasty, the blood metal ion concentration was compared with that of conventional total hip arthroplasty patients. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Total hip replacement arthroplasty using modular dual mobility cup and Total hip replacement arthroplasty using conventional acetabular cup
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteSouth Korea
Study dates
5 Sep 2019to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Over 60 years of age. Femoral neck fracture or hip joint disease. Garden stage III, IV
  • Comorbidities: American Society of Anesthesiology (ASA) grade III or less, Charlson comorbidity 6 points or less
  • Daily activity: UCLA score 4 or higher, Koval score 4 or lower
  • Including patients with neuromuscular disorder and cognitive impairment

Who cannot join

  • Revision arthroplasty
  • In case of factors other than fretting corrosion of the index arthroplasty that can cause an increase in serum metal ion level - In case of undergoing surgery using metal on other joints before this operation, vitamin B user
  • Patients with abnormal kidney function in which Blood urea nitrogen (BUN) and Cr are out of normal values
  • Pathologic fracture
  • If you have metabolic bone disorder, exclude osteoporosis (ex. Paraneoplastic syndrome, renal osteodystrophy, Vit D disorder, hormonal disorder)

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • KoreaUGuroH

    Seoul, 08308

Other trials in South Korea

About this study

Official title: Metal Ion Levels in Total Hip Arthroplasty (THA) With Modular Dual Mobility (MDM) Cup Compared to Conventional Total Hip Arthroplasty (THA) - A Multicenter Prospective Randomized Controlled Study

After total hip arthroplasty using an 'Modular Dual Mobility' acetabular cup, which is effective in reducing the risk of dislocation, one of the serious complications occurring after total hip arthroplasty, the blood metal ion concentration was compared with that of conventional total hip arthroplasty patients. This is a multicenter prospective randomized comparative study.

Read the detailed description

Dislocation after total hip arthroplasty is a very serious complication not only for the patient but also for the operator, and is the second most common complication after joint dissociation. The incidence of dislocation after conventional total hip arthroplasty has been reported to be about 0.2 to 7%, and the frequency is higher in elderly patients with hip fractures and has been reported up to about 9%. In patients at high risk of dislocation, total hip arthroplasty using a dual mobility acetabular cup has the effect of reducing the risk of dislocation, and its use has been increasing in recent years. The dual mobility acetabular cup used in this study was developed in a form that can be screwed through the acetabular cup to compensate for the shortcomings of the dual mobility acetabular cup used in the past. The modular dual mobility acetabular cup, which can be fixed with screws, has a metal liner inserted therein, so there is a possibility that the concentration of metal ions in the blood may rise. Until now, studies on the concentration of metal ions in the blood after total hip arthroplasty using an modular dual mobility acetabular cup have been reported very rarely, and the results are also reported differently [4-7]. In addition, no prospective comparative study on blood metal ion concentrations after total hip arthroplasty using an modular dual mobility acetabular cup in elderly patients with femoral neck fractures has been reported. The release of metal ions due to metal corrosion or metal friction in the artificial joint is a rare phenomenon, but it can cause serious complications in the body. It has been suggested through case reports that it can cause abnormalities in the nervous system and cardiovascular system by increasing the concentration of metal ions in the body as well as bone complications such as osteolytic artificial joint relaxation pseudotumor around the artificial joint [5-7] , and a comparative analysis of the modular dual mobility acetabular cup with the conventional acetabular cup to see if there is any problem of metal ion rise in the body due to the release of metal ion concentration is a very important and meaningful study for both doctors and patients performing hip arthroplasty. In addition, it is expected that the medical and social contribution of this research will not be small, considering that the artificial prosthesis used as a material for metal-to-metal surface replacement surgery in the hip joint arthroplasty field was recalled a few years ago and caused a big wave around the world.

Matsen et al. defined significant elevation when Cobalt ≥ 1.6 mcg/L, based on previous literature that required revision for adverse local tissue reaction (ALTR). A guideline for follow-up of a metal artificial joint is attached as an appendix. Nam et al. (J Arthroplasty, 2016) reported that the frequency of patients with cobalt ion levels deviating from the normal reference values at 1 year after surgery was 4/26 (15.3%), MDM THA vs. 1/17 (5.9%) reported that it was Conventional THA. Matsen et al. did not specify the timing of the initial measurement of the ion concentration, but said that if abnormal values were observed, they were followed continuously every 6 months. Based on the previous literature that required revision for adverse local tissue reaction (ALTR), Cobalt ≥ 1.6 mcg/L was defined as significant elevation. As a result of following 100 patients, it was confirmed that the cobalt concentration was outside the normal range in 21 patients (21%), and a significant increase in the cobalt ion concentration of 1.6 mcg/L or more was reported in 9 patients (9%). And two of them had ALTR on MRI.

Metal ions can be released and the concentration of metal ions in the body can be increased in not only artificial joint replacement surgery using the assembled double movable acetabular cup but also in the solid acetabular cup. The acetabular cup and the femoral stem may be worn during joint movement due to the collision phenomenon, and if the acetabular cup screw is loosened or incorrectly inserted and corroded and worn, metal ions may be released along with the surrounding osteolysis.

The reason for performing randomization in this study is first, to ensure that the subject's characteristics do not affect the group to be assigned, so that the probability that each subject will receive surgery with which of the two substitutes is equally applied. , Second, in order to maximize the internal validity of the research results, to make the characteristics of the subjects to which the substitutes to be compared belong to be as similar as possible except for the substitutes assigned to them. Third, since statistical analysis was developed based on the theory of probability, The reason for randomizing the assignment of study subjects to the substitutions used is because it satisfies the prerequisites for applying statistical techniques to the analysis of research data.

Comparing and analyzing the difference in the concentration of metal ions in the blood through randomization is an important study that can confirm whether the difference in metal ion release can be caused by the difference in the binding mechanism between the two acetabular cups. It is an important complication after joint arthroplasty that can cause side effects and can cause harm to internal organs or revision surgery. Therefore, analyzing it is very important and meaningful research.

The purpose of this study was to compare the blood metal ion concentration in elderly patients after total hip arthroplasty using an modular dual mobility acetabular cup with the results of the conventional total hip arthroplasty patient group in a multicenter prospective study. In addition, we intend to compare clinical and radiological factors that are commonly evaluated during outpatient follow-up after surgery.

Being tested
Total hip replacement arthroplasty using modular dual mobility cup, Total hip replacement arthroplasty using conventional acetabular cup
Keywords
Total hip arthroplasty, Metal ion, Dual mobility, Total hip replacement
Medical subject headings
Femoral Neck Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total hip replacement arthroplasty using modular dual mobility cupProcedure or surgery

    In a total hip replacement (also called total hip arthroplasty), the damaged bone and cartilage is removed and replaced with prosthetic components

  • Total hip replacement arthroplasty using conventional acetabular cupProcedure or surgery

    In a total hip replacement (also called total hip arthroplasty), the damaged bone and cartilage is removed and replaced with prosthetic components

Study groups in NCT05181566
Study groupRoleWhat they receive
Modular dual mobility groupExperimentalA group of patients who underwent total hip replacement arthroplasty using a modular dual mobility cup
Receives: Procedure: Total hip replacement arthroplasty using modular dual mobility cup
Conventional groupActive comparatorA group of patients who underwent total hip replacement arthroplasty using a conventional acetabular cup
Receives: Procedure: Total hip replacement arthroplasty using conventional acetabular cup

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Metal ion level

    Measurement of metal ion concentration in blood serum

    Measured: Baseline (pre op.), post op. 12 months

Secondary outcomes (12)
  1. Change in Clinical measurement (Pain-visual analog scale)

    Pain-visual analog scale

    Measured: Post op. 6 months, post op. 12 months, post op. 24 months

  2. Change in Clinical measurement (Harris hip score)

    Harris hip score

    Measured: Post op. 6 months, post op. 12 months, post op. 24 months

  3. Change in Clinical measurement (Oxford hip score)

    Oxford hip score

    Measured: Post op. 6 months, post op. 12 months, post op. 24 months

  4. Change in Clinical measurement (UCLA score)

    University of California at Los Angeles (UCLA) activity score

    Measured: Post op. 6 months, post op. 12 months, post op. 24 months

  5. Change in Radiological measurement (Hip x-ray)

    Acetabular cup inclination (degree)

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  6. Change in Radiological measurement (CT)

    Anterior angle (degree, measured by computed tomography)

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  7. Change in Radiological measurement (Long leg x-ray)

    Leg length difference (mm)

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  8. Post operative complication (Dislocation)

    Dislocation or not

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  9. Post operative complication (Infection)

    Infection or not

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  10. Post operative complication (Osteolysis)

    Osteolysis or not

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  11. Post operative complication (Implant dissociation)

    Implant dissociation or not

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

  12. Revision surgery

    Revision surgery or not

    Measured: Baseline (immediate post op.), post op. 6 months, post op. 12 months, post op. 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2022
  2. Study start5 Sep 2019
  3. Primary completion3 Aug 2021
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05181566
Sponsor's protocol ID
2019GR0112
Status last verified
Mar 2021
First submitted
3 Dec 2021
Last updated
6 Jan 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Total hip replacement arthroplasty using modular dual mobility cup and Total hip replacement arthroplasty using conventional acetabular cup in people with Femur Neck Fracture and Arthroplasty Complications, run by Korea University Guro Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Metal ion level (time frame: Baseline (pre op.), post op. 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in